Figure 9

Uptake of [64Cu]Cu-NOTA-B11-diabody in B16-F10 PD-L1KO and B16-F10 hPD-L1+ melanoma tumors. *p = 0.0092 B16-F10 hPD-L1+ vs B16-F10 PD-L1KO (n = 4).
Uptake of [64Cu]Cu-NOTA-B11-diabody in B16-F10 PD-L1KO and B16-F10 hPD-L1+ melanoma tumors. *p = 0.0092 B16-F10 hPD-L1+ vs B16-F10 PD-L1KO (n = 4).